|
Market Closed -
Australian S.E.
04:10:15 28/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 0.1450 AUD | -3.33% |
|
-3.33% | -3.33% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 74.43 | - | - |
| Change | - | - | 343.99% | -38.27% | - | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 56.53 | 51.03 | 57.03 |
| Change | - | - | 241.42% | -39.03% | -9.73% | 11.76% |
| P/E | -2.64x | -3.27x | -14.3x | -6.3x | -20.7x | -13.2x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.2x | 0.3x | -0.2x |
| Capitalization / Revenue | - | - | - | - | 7.83x | 7.83x |
| EV / Revenue | - | - | - | - | 5.37x | 6x |
| EV / EBITDA | - | - | -11.2x | -4.92x | -12.8x | -9.51x |
| EV / EBIT | - | - | -11.1x | -4.87x | -12.4x | -9.35x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.007 | -0.011 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 9.5 | 9.5 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -4 | -6 |
| EBIT 1 | - | - | -8.389 | -11.6 | -4.1 | -6.1 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -4.1 | -6.1 |
| Net Debt 1 | - | - | -27.85 | -17.9 | -23.4 | -17.4 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1450 | 0.1450 | 0.1450 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - | - |
| Announcement Date | 30/5/23 | 30/5/25 | 29/5/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.3x | - | -4.92x | - | 53.4M | |
| 20.59x | 7.25x | 14.66x | 1.42% | 69.54B | |
| 36.89x | 9.62x | 29.41x | 0.04% | 64.97B | |
| 30.69x | 6.58x | 17.2x | -.--% | 26.51B | |
| -74.93x | 13.98x | -67.43x | -.--% | 25.89B | |
| -15.61x | 5.94x | -7.46x | -.--% | 25.64B | |
| 58.27x | 21.67x | 43.95x | 0.26% | 20.22B | |
| 27.27x | 5.11x | 16.98x | -.--% | 19.98B | |
| 1415.29x | 39.34x | 858.54x | -.--% | 15.69B | |
| 16.84x | 5x | 11.66x | -.--% | 13.49B | |
| Average | 150.90x | 12.72x | 91.26x | 0.19% | 28.2B | |
| Weighted average by Cap. | 93.81x | 10.79x | 57.81x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
